HANGZHOU, ZHEJIANG, CHINA, January 16, 2026 /EINPresswire.com/ -- The pharmaceutical industry is undergoing a period of ...

Advanced multimodal intelligence expands creative depth, cohesion, and flexibility for Web3-native content. SINGAPORE, ...

The global pharmaceutical industry is witnessing a steady transformation as plant-based active pharmaceutical ingredients (APIs) move from complementary roles toward becoming core components in modern ...

WASHINGTON – Venezuela’s President Nicolás Maduro was indicted in New York on federal charges of narco-terrorism conspiracy, cocaine importation conspiracy and two illegal weapons counts based on ...

President Trump on Friday announced new agreements with nine pharmaceutical manufacturers aimed at reducing certain prescription drug prices. "Starting next year, American drug prices will come down ...

President Donald Trump has signed an executive order making some big changes to marijuana policy, the most substantial since 1970. On Dec. 18, Trump ordered the government to stop classifying ...

The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug. By Gina Kolata Gina Kolata has ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Cdymax Pharma has been slapped with a warning letter from the FDA outlining two observations against the Bangalore, India-based API maker, both linked to testing shortfalls. The letter comes in ...

EAST RUTHERFORD, N.J., Oct. 22, 2025 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced a $120 million investment to expand its U.S.

BRINGING MOST-FAVORED-NATION DRUG PRICING TO WOMEN: Today, President Donald J. Trump announced the third agreement with a leading pharmaceutical manufacturer to bring American drug prices in line with ...